Skip to main content
IBB logo
IBB
(NASDAQ)
iShares Biotechnology ETF
$177.00-- (--)
Loading... - Market loading

IBB ETF: iShares Biotechnology ETF - Price, Holdings & Analysis

iShares Biotechnology ETF Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fund characteristics, expense ratio, dividend yield, and performance metrics

Day's Range$171.79 - $176.58
52-Week High$179.64
52-Week Low$123.61
Open$174.82
Volume965.60K
Average Volume (3M)1.48M
Assets (AUM)7.84B
Expense Ratio0.44%
Total Holdings254
Inception DateFeb 4, 2001
1 Day Change1.94%
1 Month Change4.86%
6 Month Change2.85%
YTD Change4.73%
1 Year Change41.67%
52-Week Change41.02%
5 Year Change10.28%
10 Year Change102.59%
50-Day MA$170.50
200-Day MA$165.35
RSI62.02
Stochastic %K96.80
Stochastic %D85.21
Annual Dividend$0.41
Dividend Yield0.23%
Last Dividend Ex-DateJun 15, 2026
Dividend Growth YoY7.51%

Frequently Asked Questions About iShares Biotechnology ETF

What is the current price of IBB?

The latest IBB price is $173.64. The 52-week range is $123.61–$179.64. IBB has returned 41.0% over the past 52 weeks.

What is the expense ratio for IBB?

IBB's annual expense ratio is 0.44%. This represents the yearly cost of holding the fund, deducted from total returns. Compare with similar Equitys in the ETF Screener.

Does IBB pay dividends?

Yes, IBB pays a 0.23% dividend yield. The last ex-dividend date was 2026-06-15. View full dividend history in the Dividends section.

What are the top holdings of IBB?

IBB's largest holdings are Vertex Pharmaceuticals Incorporated (7.5%), Gilead Sciences, Inc (7.4%), Amgen Inc. (7.4%) (combined weight: 22.4%). The fund holds 254 total positions. View the complete portfolio breakdown in the Holdings section.

How does IBB compare to similar ETFs?

Compare IBB (0.44% expense ratio, $7.84B AUM) against similar Equitys using the ETF Screener. Filter by expense ratio, dividend yield, and performance to find alternatives.